Tempest Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TPST and other ETFs, options, and stocks.

About TPST

Tempest Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development and discovery of small molecule drugs for the treatment of cancer. The company was founded in 2011 and is headquartered in Brisbane, CA.

CEO

Stephen R. Brady

CEOStephen R. Brady

Employees

Employees17

Headquarters

Brisbane, California

HeadquartersBrisbane, California

Founded

2011

Founded2011

Employees

Employees17

TPST Key Statistics

Market cap

35.27M

Market cap35.27M

Price-Earnings ratio

-0.53

Price-Earnings ratio-0.53

Dividend yield

—

Dividend yield—

Average volume

506.51K

Average volume506.51K

High today

$0.84

High today$0.84

Low today

$0.801

Low today$0.801

Open price

$0.81

Open price$0.81

Volume

201.66K

Volume201.66K

52 Week high

$6.00

52 Week high$6.00

52 Week low

$0.6986

52 Week low$0.6986

Tempest Therapeutics

Why Robinhood?

Tempest Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development and discovery of small molecule drugs for the treatment of cancer. The company was founded in 2011 and is headquartered in Brisbane, CA. Show more

TPST Key Statistics

Tempest Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development and discovery of small molecule drugs for the treatment of cancer. The company was founded in 2011 and is headquartered in Brisbane, CA.